To own Northrop Grumman, you need to believe that large, long cycle defense programs and a US$105b backlog can keep factories busy while capital spending on munitions, solid rocket motors and aircraft capacity earns its keep over time. The reaffirmed 2026 sales outlook and expectation for higher fourth quarter revenue point to a steady near term operating backdrop rather than a step change.
The key short term swing factor is execution on complex fixed price work as production ramps on programs like B 21, Sentinel and missile systems. Cost surprises on those contracts, or any shift in U.S. funding priorities for major air and missile systems, remain the biggest operational risk, and this latest update does not materially change that equation.
The most relevant update for this story is the third quarter 2026 earnings release. Northrop Grumman reported US$11,122m of quarterly sales and US$1,124m of net income, with nine month revenue of US$31,879m and net income of US$3,093m. Earnings per share from continuing operations also came in higher than the prior year on both a basic and diluted basis.
Those figures, paired with reiterated full year guidance, indicate that current demand and program performance are broadly lining up with management’s plan. For you as a shareholder or prospective buyer, the takeaway is straightforward: near term catalysts still hinge on how cleanly the business converts its record order book in areas like munitions and national security space into profitable production without fresh contract charges.
Northrop Grumman's current analyst narrative points to revenue of US$51.0b and earnings of US$4.7b by 2029, based on forecast annual top line growth of 5.9% and an earnings step up of about US$0.2b from the US$4.5b level cited for today.
Uncover why Northrop Grumman's fair value indicates a 13% potential upside to its current price, which could narrow quickly.
Some of the lowest forecast analysts focus on margin risk at Northrop Grumman. They were modeling revenue of about US$49.7b and earnings near US$4.2b by 2029, compared with the consensus US$51.0b and US$4.7b. You can read this as a much more cautious story, and the latest guidance update may eventually shift those views in either direction.
Explore another Northrop Grumman fair value estimate, including one that suggests it could be worth just $569.65.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If you want to stress test your view on Northrop Grumman, it can help to compare it with other businesses that have different risk, income and balance sheet profiles using the Simply Wall St Screener.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com